Exchange: NASDAQ·Updated 07:30 PM EDT
News
all
press releases
Anika Stock Gains 43.4% in the Past 3 Months: Here Is Why?
ANIK's strong sales momentum and raised 2026 guidance bolster investor confidence, while Cingal and Hyalofast advance its pipeline.
Zacks
More News
TEVA's Ecopipam Wins FDA Priority Tag in Pediatric Tourette Syndrome
Teva's ecopipam secures FDA priority review for pediatric Tourette syndrome, potentially bringing the first new therapy in over a decade.
Zacks
Reasons Why Investors Should Consider Betting on PGEN Stock
Precigen's Papzimeos drives rapid revenue growth, while market exclusivity, global expansion and its pipeline add long-term potential.
Zacks
Nuvectis Stock Surges Around 97% in 3 Months: Here's Why
NVCT's 97% three-month gain reflects optimism around its expanding pipeline, with NXP100 and NXP200 offering new value drivers.
Zacks
ARGX Announces Positive Phase III Data on Vyvgart Hytrulo, Stock Up
argenx's shares jump 16% as Vyvgart Hytrulo delivered positive phase III ALKIVIA data, supporting its potential label expansion in autoimmune myositis.
Zacks
Are You Looking for a Top Momentum Pick? Why Precigen, Inc. (PGEN) is a Great Choice
Does Precigen, Inc. (PGEN) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks
Precigen, Inc. (PGEN) Q2 Earnings and Revenues Surpass Estimates
Precigen (PGEN) delivered earnings and revenue surprises of +350.00% and +97.62%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Precigen Reports Second Quarter 2026 Financial Results Highlighted by Accelerating PAPZIMEOS Revenue Growth
Precigen Reports Second Quarter 2026 Financial Results Highlighted by Accelerating PAPZIMEOS Revenue Growth Precigen Reports Second Quarter 2026 Financial Results Highlighted by Accelerating PAPZIMEOS Revenue Growth PR Newswire GERMANTOWN, Md., Aug. 4, 2026 PAPZIMEOS net revenue of $53.1 million in...
PR Newswire
Precigen to Announce Second Quarter 2026 Financial Results and Provide Business Updates on August 4
Precigen to Announce Second Quarter 2026 Financial Results and Provide Business Updates on August 4 Precigen to Announce Second Quarter 2026 Financial Results and Provide Business Updates on August 4 PR Newswire GERMANTOWN, Md., July 21, 2026 GERMANTOWN, Md., July 21, 2026 /PRNewswire/ -- Precigen...
PR Newswire
What Does the Sale of Precigen Shares Worth $1.1 Million by the CFO Mean for Investors?
Key PointsCFO Harry Thomasian Jr. sold 200,000 shares of Precigen common stock across two transactions for a total value of approximately $1.11 million, based on a weighted average price of $5.57 per share...
Nasdaq News: Markets

Advertisement|Remove ads.